By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Sequencing the Insurance Genome
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Health Reform > Sequencing the Insurance Genome
Health ReformMedical InnovationsNewsPolicy & LawPublic Health

Sequencing the Insurance Genome

etwilson
etwilson
Share
4 Min Read
personalized medicine
SHARE

personalized medicineIf you build it, they will come.

The classic Field of Dreams tagline seems to be—perhaps unconsciously—informing the new Precision Medicine Initiative announced by President Obama as he heads into his lame duck period.

personalized medicineIf you build it, they will come.

The classic Field of Dreams tagline seems to be—perhaps unconsciously—informing the new Precision Medicine Initiative announced by President Obama as he heads into his lame duck period.

More Read

Innovations and Cooperation for World Water Week
Neuro Drug Developer iPierian Nets $30M
Mastering the Business of Healthcare [INFOGRAPHIC]
Positive Health and the Heart
What the Election Means for Health Care

Those in the field may recognize this as a next-generation re-branding of personalized medicine, the not-quite-new idea that treatment can be more targeted, more effective, and more personal than current best practices typically entail.

The White House’s Precision program builds on the premise of personalized medicine to specifically target cancer. The multi-million dollar investment is intended to move cancer treatment beyond management—which responds to symptoms and is decidedly reactive—and into prevention. Large-scale genetic sequencing will enable doctors to identify cancer in patients long before they exhibit symptoms, advancing screening to the point that proactive, lifesaving measures become the norm, and a cure is finally feasible.

If—and it is, at this point, still a Mount Everest of an ‘if’—the new initiative succeeds in overcoming all of the scientific, organizational, and practical challenges inherent in this undertaking, there remains a significant policy hurdle that no one involved has yet begun to address: access.

The Affordable Care Act (ACA—or Obamacare, if you prefer) came under fire during its initial implementation for denying patients access to the best cancer treatment hospitals in the country. In fact, this was not so much a feature of the new ACA as it was an integrated failure of the insurance marketplace.

The ACA hinges on getting more Americans covered by health insurance. As the name suggests, this requires many to purchase the most affordable—and therefore limited—coverage available on the new marketplaces. Making these plans affordable requires some cost-cutting on the part of the providers, achieved in part by severely limiting provider networks.

The most modern, cutting-edge hospitals are expensive to add to networks, and so are excluded from many of the entry-level (bronze, in the parlance of the marketplace) or even higher-premium plans (silver and gold).

So even without the next generation of medicine on the table, access to the best treatment available is, at best, extremely limited.

A miracle cure for cancer won’t go far unless the precision screening being developed is provided under more than a minority of hospital networks. More accurate, early screening alone would be worth some celebration. But the President’s allocations also specifically include the FDA, a clear sign that a cure is expected to accompany the genetic risk-analysis being developed.

The ACA failed to stop insurers from top-loading their tiered drug formularies to avoid paying to expensive patients and their treatments. There is no reason to expect that any forthcoming precision cancer drugs will somehow escape this profit-minded tactic.

For personalized care to be truly revolutionary, it needs to do more than take the best elements of scientific knowledge, technology, and virtual connectivity; it needs to be available to the general public who stand to benefit most. With all of the focus on the tech and modernity of personalized care, the importance of the policy challenges seems to be missing—undermining the very significance any potential success the new initiative might have enjoyed.

personalized medicine / shutterstock

Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

contamination
Batch Failures And The Hidden Costs Of Contamination
Health Infographics
October 21, 2025
Medication Management For Seniors
Simplifying Medication Management For Seniors
Infographics Senior Care
October 21, 2025
Guide To Pursuing a Career in Nursing as a Foreigner in the USA
Collaboration Is the Prescription for Better Patient Care
Health
October 20, 2025
Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025

You Might also Like

patient tracking systems for medical staff and innovation
Medical InnovationsTechnology

Patient Tracking Systems: Improving Facilities for Patients and Medical Staff

January 2, 2023
pediatrics
Health care

7 Strategies To Help Children Feel More Comfortable During Doctor Visits

July 22, 2019
ID-100249250
BusinessHospital AdministrationPolicy & Law

8 Months Until ICD-10 Implementation: What to Know

February 23, 2015
healthcare.gov homepage
Health ReformPolicy & LawPublic Health

Interest in Obamacare Slowly Increasing

November 8, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?